Discontinued — last reported Q3 '18

Current Assets

Derivative Assets - Not Designated as Hedging Instruments

West Pharmaceutical Services Derivative Assets - Not Designated as Hedging Instruments decreased by 36.8% to $4.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 63.6%, from $13.20M to $4.80M. Over 5 years (FY 2020 to FY 2025), Derivative Assets - Not Designated as Hedging Instruments shows an upward trend with a 20.4% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2017
Last reportedQ3 2018
Metric ID: derivative_assets_non_hedging

Historical Data

14 periods
 Q4 '21Q1 '22Q4 '22Q1 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$14.80M$23.30M$4.50M$3.50M$2.20M$10.30M$14.70M$9.90M$18.30M$13.20M$47.00M$27.00M$7.60M$4.80M
QoQ Change—+57.4%-80.7%-22.2%-37.1%+368.2%+42.7%-32.7%+84.8%-27.9%+256.1%-42.6%-71.9%-36.8%
YoY Change——-69.6%-85.0%-51.1%+194.3%——+731.8%+28.2%+219.7%+172.7%-58.5%-63.6%
Range$2.20M – $47.00M
CAGR-29.3%
Avg YoY Growth+101.9%
Median YoY Growth-11.5%
Current Streak3 quarters decline

Frequently Asked Questions

What is West Pharmaceutical Services's derivative assets - not designated as hedging instruments?
West Pharmaceutical Services (WST) reported derivative assets - not designated as hedging instruments of $4.80M in Q1 2026.
How has West Pharmaceutical Services's derivative assets - not designated as hedging instruments changed year-over-year?
West Pharmaceutical Services's derivative assets - not designated as hedging instruments decreased by 63.6% year-over-year, from $13.20M to $4.80M.
What is the long-term trend for West Pharmaceutical Services's derivative assets - not designated as hedging instruments?
Over 5 years (2020 to 2025), West Pharmaceutical Services's derivative assets - not designated as hedging instruments has grown at a 20.4% compound annual growth rate (CAGR), from $3.00M to $7.60M.